ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 131 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,000 | -37.9% | 14,275 | +22.3% | 0.00% | – |
| Q3 2020 | $29,000 | -80.3% | 11,673 | -76.1% | 0.00% | -100.0% |
| Q2 2018 | $147,000 | -25.4% | 48,805 | -2.9% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | -3.4% | 50,238 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $204,000 | -32.0% | 49,236 | +0.6% | 0.00% | -50.0% |
| Q3 2017 | $300,000 | +13.6% | 48,930 | +15.3% | 0.00% | 0.0% |
| Q2 2017 | $264,000 | +91.3% | 42,430 | +73.5% | 0.00% | +33.3% |
| Q3 2016 | $138,000 | +5.3% | 24,460 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $131,000 | -26.8% | 23,784 | -1.2% | 0.00% | -25.0% |
| Q1 2016 | $179,000 | +49.2% | 24,084 | +67.2% | 0.00% | +33.3% |
| Q4 2015 | $120,000 | -11.1% | 14,408 | -3.9% | 0.00% | -25.0% |
| Q3 2015 | $135,000 | – | 14,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |